Wordt geladen...
Cisplatin Decreases ENaC Activity Contributing to Renal Salt Wasting Syndrome
Cisplatin (CDDP) is an important anticancer drug. A common side effect of CDDP is renal salt and water-wasting syndrome (RSWS). The origin of RSWS is obscure. Emerging evidence, though, suggests that broad inhibition of sodium transport proteins by CDDP may result in decreases in tubular reabsorptio...
Bewaard in:
| Gepubliceerd in: | Cancers (Basel) |
|---|---|
| Hoofdauteurs: | , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
MDPI
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7464492/ https://ncbi.nlm.nih.gov/pubmed/32752278 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12082140 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|